Treating postpartum depression with brexanolone / Jessica Burval, Rachel Kerns, Kim Reed
Series: Nursing 2020. 50 : 5, pages 48-53 Publication details: May 2020Content type:- text
- unmediated
- volume
Current library | Call number | Status | Date due | Barcode |
---|---|---|---|---|
Manila Tytana Colleges Library REFERENCE SECTION | Not for loan |
The FDA has approved brexanolone specifically for treatment of adults with postpartum depression (PPD). Administered I.V., it can relieve severe signs and symptoms of PPD within days rather than weeks. This article discusses the benefits and risks of brexanolone as a treatment for PPD, including nursing considerations and patient teaching.
Nursing.
There are no comments on this title.